BWP
COCH icon

BlueStem Wealth Partners’s Envoy Medical COCH Stock Holding History

BlueStem Wealth Partners’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.28K Hold
10,454
– – ﹤0.01% 127
2026
Q1 		$6.95K Hold
10,454
– – ﹤0.01% 124
2025
Q4 		$6.91K Hold
10,454
– – ﹤0.01% 125
2025
Q3 		$8.11K Hold
10,454
– – ﹤0.01% 124
2025
Q2 		$14.8K Hold
10,454
– – ﹤0.01% 119
2025
Q1 		$13.6K Hold
10,454
– – ﹤0.01% 103
2024
Q4 		$14.9K Buy
+10,454
New +$23.7K ﹤0.01% 101

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCA
DSG Capital Advisors Edina, Minnesota $704M AUM 34.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

BlueStem Wealth Partners's COCH Position: Q2 2026 in Review

BlueStem Wealth Partners held its Envoy Medical (COCH) position steady in Q2 2026 at 10,454 shares worth $8.28K. The position accounts for ﹤0.01% of the portfolio, ranked #127.

BlueStem Wealth Partners first reported a position in COCH in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.9K in Q4 2024. 32 funds tracked by Wall St. Rank hold COCH as of Q2 2026.

  • BlueStem Wealth Partners held 10,454 shares of Envoy Medical worth $8.28K as of Q2 2026.
  • BlueStem Wealth Partners left its Envoy Medical share count unchanged in Q2 2026.
  • Envoy Medical made up ﹤0.01% of BlueStem Wealth Partners's portfolio in Q2 2026, its #127 holding.
  • BlueStem Wealth Partners first reported a position in Envoy Medical in Q4 2024 and has held it in 7 quarters since.
  • BlueStem Wealth Partners's Envoy Medical position peaked at $14.9K in Q4 2024.
  • 32 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2026.

Based on BlueStem Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.